Page last updated: 2024-09-04

pomalidomide and moxifloxacin

pomalidomide has been researched along with moxifloxacin in 1 studies

Compound Research Comparison

Studies
(pomalidomide)
Trials
(pomalidomide)
Recent Studies (post-2010)
(pomalidomide)
Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010) (moxifloxacin)
6231215523,1575521,690

Protein Interaction Comparison

ProteinTaxonomypomalidomide (IC50)moxifloxacin (IC50)
DNA gyrase subunit BStaphylococcus aureus5.1033
DNA gyrase subunit AEscherichia coli K-121.4
DNA gyrase subunit BEscherichia coli K-121.4
DNA topoisomerase 4 subunit AStaphylococcus aureus0.8
DNA gyrase subunit AStaphylococcus aureus7.25
DNA gyrase subunit BMycobacterium tuberculosis H37Rv8.525
DNA gyrase subunit AMycobacterium tuberculosis H37Rv8.66

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assaf, M; Liu, L; Mondal, SA; O'Mara, E1

Trials

1 trial(s) available for pomalidomide and moxifloxacin

ArticleYear
A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
    Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:2

    Topics: Adult; Angiogenesis Inhibitors; Anti-Bacterial Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Male; Moxifloxacin; Thalidomide; Treatment Outcome

2016